Immunohistochemical study of the expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues
Open Access
- 1 March 2001
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 54 (3) , 210-213
- https://doi.org/10.1136/jcp.54.3.210
Abstract
Aim—To study the protein expression patterns of MUC5AC and MUC6 in normal and diseased breast tissues and to compare their expression with that of a mucin (MUC1) normally expressed in mammary tissues. Methods—Formalin fixed, paraffin wax embedded tissue from 69 cases of invasive breast carcinoma and surrounding breast tissue was studied immunohistochemically with monoclonal antibodies against MUC1 (SM3), MUC5AC (CLH2), and MUC6 (CLH6), using the avidin–biotin–peroxidase method. Results—MUC5AC was detected in five of 68 cases of invasive carcinoma including one of three cases of pure colloid carcinoma. MUC5AC expression in the adjacent normal breast epithelium was present in one of 29 cases and in one of two cases of ductal carcinoma in situ. None of 15 cases of ductal hyperplasia without atypia was positive for MUC5AC. MUC6 was present in 15 of 65 cases of invasive carcinoma, in four of 29 cases of normal adjacent epithelium, two of 15 cases of ductal hyperplasia without atypia, and one of two cases of ductal carcinoma in situ. MUC1 immunoreactivity detected by the SM3 antibody was present in 50 of the 67 cases of invasive carcinoma, but expression was also detected in benign epithelium. All invasive carcinomas expressing MUC5AC were positive for MUC1 and four were positive for MUC6. No significant association was found between the expression of these mucins and tumour size, histological grade, node status, oestrogen receptor status, p53 positivity, or c-ErbB-2 overexpression. Conclusions—This study documents the expression of two different mucins (MUC5AC and MUC6) not described as being expressed by normal breast tissues in a minority of breast carcinomas, as well as in normal and hyperplastic epithelium. Although the role of mucins in malignant transformation and the progression of breast cancer is not well understood, in some cases, there is probably an upregulation of several genes that encode distinct mucin proteins.Keywords
This publication has 18 references indexed in Scilit:
- Immunohistochemical Study of the Expression of MUC6 Mucin and Co-expression of Other Secreted Mucins (MUC5AC and MUC2) in Human Gastric CarcinomasJournal of Histochemistry & Cytochemistry, 2000
- Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breastInternational Journal of Cancer, 1999
- Epithelial Mucin GenesAnnual Review of Physiology, 1995
- Prognostic significance of muc1 epithelial mucin expression in breast cancer*1Human Pathology, 1995
- Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.1993
- Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product.1993
- Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization.Journal of Histochemistry & Cytochemistry, 1993
- Heterogeneity of mucin gene expression in normal and neoplastic tissues.1993
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM‐3 is selectively exposed in a range of primary carcinomasInternational Journal of Cancer, 1989